The ABPI has welcomed the decision by the Department of Health (DH) to appoint a Director General for Innovation Growth and Technology.
News of the post was announced at the ABPI Annual Conference by Earl Howe, Parliamentary Under Secretary of State at the Department of Health. The post will oversee the Medicines, Pharmacy, and Industry Division. The appointment is intended to strengthen the government’s focus on the innovation growth and technology agenda and strengthen the Department’s capacity in this area. The post is due to be filled in the summer.
Commenting on the announcement, ABPI Chief Executive Stephen Whitehead said: “I am very pleased that through the creation of this new post the Department is making innovation and growth a higher priority. When the strategy for UK Life Sciences was published in December 2011, the Government made a commitment to make the UK a global leader in the life sciences sector, and earlier this year the ABPI called on the Government to provide greater leadership and accept a growing accountability in the development of the life sciences sector. This appointment will contribute to meeting these objectives.
“I hope that this appointment will lead to an increased focus on delivering the Innovation Health and Wealth agenda, ensuring that the health system in the UK is a hotbed of innovation and growth. The pharmaceutical industry is committed to play its part in defining the next steps and working together with government as they strengthen their focus on this important agenda”.